lovastatin has been researched along with Bone Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beutler, JA; Goetz, M; Goncharova, EI; Hao, X; Henrich, CJ; Huang, S; Jia, L; Kambala, A; Khanna, C; LeBlanc, A; Long, SA; Ren, L; Wilson, J; Yang, X | 1 |
| Chen, J; Huang, Y; Jin, M; Liu, J; Shao, H; Zhang, J; Zhao, H | 1 |
| Fritz, G; Huelsenbeck, J; Nilsson, S | 1 |
| Brion, R; Ebetion, FH; Heymann, D; Moriceau, G; Redini, F; Roelofs, AJ; Rogers, MJ | 1 |
| Abe, K; Asami, S; Kodama, T; Konishi, K; Oikawa, S; Sugiyama, M | 1 |
5 other study(ies) available for lovastatin and Bone Cancer
| Article | Year |
|---|---|
Identification of potential modulators of osteosarcoma metastasis by high-throughput cellular screening of natural products.
Topics: Biological Products; Bone Neoplasms; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Drugs, Chinese Herbal; High-Throughput Screening Assays; Humans; Lovastatin; Melia; Monascus; Osteosarcoma; Plant Extracts; Pyridines; Seeds | 2021 |
miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61.
Topics: 3' Untranslated Regions; Antagomirs; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cysteine-Rich Protein 61; Epithelial-Mesenchymal Transition; Humans; Lovastatin; MicroRNAs; Osteosarcoma; RNA Interference; RNA, Small Interfering; Signal Transduction; Sterol Regulatory Element Binding Protein 2; Up-Regulation | 2018 |
Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Proliferation; Cisplatin; Diphosphonates; DNA Damage; Doxorubicin; Fibrosarcoma; Humans; Lovastatin; Metformin; Mevalonic Acid; Osteosarcoma; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2011 |
Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Proliferation; Diphosphonates; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Mice; Mice, Inbred C3H; Osteosarcoma; Protein Prenylation; Rats; Tumor Cells, Cultured | 2012 |
Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
Topics: Anti-Bacterial Agents; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Bone Neoplasms; Cloning, Molecular; Disulfides; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Indole Alkaloids; Lovastatin; Mevalonic Acid; Osteoporosis; Osteosarcoma; Pravastatin; Promoter Regions, Genetic; RNA, Messenger; Simvastatin; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured | 2000 |